Zoetis Inc.

ZTS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $9.47B $9.26B $8.54B $8.08B $7.78B $6.68B $6.26B
Cost of Revenue $2.67B $2.72B $2.56B $2.45B $2.30B $2.06B $1.99B
Gross Profit $6.80B $6.54B $5.98B $5.63B $5.47B $4.62B $4.27B
Gross Margin 71.8% 70.6% 70.0% 69.6% 70.4% 69.2% 68.2%
Operating Expenses
Research & Development
SG&A Expense $2.38B $2.32B $2.15B $2.01B $2.00B $1.73B $1.64B
Operating Income $3.58B $3.36B $3.18B $2.88B $2.71B $2.23B $2.02B
Operating Margin 37.8% 36.3% 37.2% 35.6% 34.9% 33.4% 32.3%
Interest Expense $222.0M $225.0M $239.0M $221.0M $224.0M $231.0M $223.0M
Pretax Income $3.36B $3.13B $2.94B $2.66B $2.49B $2.00B $1.80B
Income Tax Expense $687.0M $637.0M $596.0M $545.0M $454.0M $360.0M $301.0M
Net Income $2.67B $2.49B $2.34B $2.11B $2.04B $1.64B $1.50B
Net Margin 28.2% 26.9% 27.4% 26.2% 26.2% 24.5% 24.0%
EPS (Basic) $6.03 $5.47 $5.08 $4.51 $4.29 $3.44 $3.14
EPS (Diluted) $6.02 $5.47 $5.07 $4.49 $4.27 $3.42 $3.11
Shares Outstanding (Basic) 422.1M 443.4M 454.2M 461.2M 468.9M 474.3M 475.5M 478.1M
Shares Outstanding (Diluted) 422.1M 443.8M 454.8M 462.3M 470.4M 476.7M 478.6M 481.8M
Dividends Per Share $2.03 $1.80 $1.56 $1.35 $1.08 $0.85 $0.69
← Newer Page 1 of 2 Older →